Proposal of the optimal and practical therapeutic strategy for gastric cancer

International Congress Series

Volumn 1255, Issue C, 2003, Pages 389-397

  Shimada, Shinya ^a   Yagi, Yasushi ^b   Shiomori, Kenji ^a   Marutsuka, Takashi ^a   Hirota, Masahiko ^a   Honmyo, Ubehiko ^a   Ogawa, Michio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b Department of Surgery   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80051709237     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(03)00598-3     Document Type: Article

References (23)

1. Lawrence, M., Shiu, M.H., Early gastric cancer. Ann. Surg. 213 (1991), 327–334.
2. Shimada, S., Yagi, Y., Shiomori, K., Honmyo, U., Hayashi, N., Matsuo, A., Marutsuka, T., Ogawa, M., Characterization and proposal of the optimal therapeutic strategy for early gastric cancer. Surgery 129 (2001), 714–719.
3. Honmyo, U., Misumi, A., Murakami, A., Mizumoto, S., Yoshinaka, I., Maeda, M., et al. A clinicopathological study on surgically resected stomachs in patients with preceding endoscopic mucosal resection for early gastric cancer. Dig. Endosc. 8 (1996), 192–198.
4. Balfour, D.C., Factors of significance in the prognosis of cancer of the stomach. Ann. Surg. 105 (1973), 733–740.
5. Maruyama, K., The most important prognostic factors for gastric cancer patients. A study using univariate and multivariate analyses. Scand. J. Gastroenterol. 22:Suppl. 133 (1987), 63–68.
6. Kida, M., Tanabe, S., Watanabe, M., Kokutou, M., Kondou, I., Yamada, Y., et al. Staging of gastric cancer with endoscopic ultrasonography and endoscopic mucosal resection. Endoscopy 30:Suppl. 1 (1998), 64–68.
7. Japanese Classification of Gastric Carcinoma, Japanese Research Society for Gastric Cancer, 1st English ed., 1999, Kanehara & Co, Tokyo.
8. Shimada, S., Tanaka, E., Marutsuka, T., Honmyo, U., Tokunaga, H., Yagi, Y., Ogawa, M., Extensive intraoperative peritoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cells. Gastric Cancer 5 (2002), 168–172.
9. Shimada, S., Yagi, Y., Honmyo, U., Shiomori, K., Yoshida, N., Ogawa, M., Involvement of more than three lymph nodes predicts poor prognosis of early gastric carcinoma. Gastric Cancer 4 (2001), 54–59.
10. T. Marutsuka, S. Shimada, K. Shiomori, N. Hayashi, Y. Yagi, T. Yamane, M. Ogawa, Mechanisms of peritoneal metastasis after operation for non serosa-invasive gastric carcinoma: an ultra-rapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin. Cancer. Res. (in press).
11. Shirasaka, T., Yamamitsu, S., Tsuji, A., Taguchi, T., Conceptual changes in cancer chemotherapy: from an oral fluoropyrimidine prodrug, UFT, to a novel oral fluoropyrimidine prodrug, S-1, and low-dose FP therapy in Japan. Invest. New Drugs 18 (2000), 315–329.
12. Sugimachi, K., Maehara, Y., Horikoshi, N., Shimada, Y., Sakata, Y., Mitachi, Y., Taguchi, T., The S-1 Gastrointestinal Cancer Study Group. An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. Oncology 57 (1999), 202–210.
13. S. Shimada, Y. Yagi, M. Kuramoto, N. Aoki, M. Ogawa, Second-line chemotherapy of combined irinotecan and low-dose cisplatin for patients with metastatic gastric carcinoma resistant to 5-fluorouracil. Oncol. Rep. (in press).
14. Bonenkamp, J.J., Songun, I., Sasako, M., Welvaart, K., Plukkar, J.T., Obertop, H., et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345 (1995), 745–748.
15. Ohgaki, M., Takahashi, T., Hagiwara, A., Yamasaki, J., Togawa, T., Effect of extensive lymph node dissection on the survival of early gastric cancer. Hepato-Gastroenterol. 46 (1999), 2096–2099.
16. Harrison, L.E., Karpeh, M.S., Brennan, M.F., Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J. Gastrointest. Surg. 2 (1998), 126–131.
17. Shimada, S., Maeno, M., Misumi, A., Akagi, M., Histochemical study of phosphorylase in proliferating cells of intestinal metaplasia and carcinoma of the human stomach. Scand. J. Gastroenterol. 19 (1984), 965–970.
18. Shimada, S., Maeno, M., Akagi, M., Hatayama, I., Sato, T., Sato, K., Immunohistochemical detection of glycogen phosphorylase isoenzymes in rat and human tissues. Histochem. J. 18 (1986), 334–338.
19. Shimada, S., Maeno, M., Misumi, A., Takano, S., Akagi, M., Antigen reversion of glycogen phosphorylase isoenzyme in carcinoma and proliferative zone of intestinal metaplasia of the human stomach. Gastroenterology 93 (1987), 35–40.
20. Shimada, S., Honmyo, U., Yagi, Y., Ikeda, T., Yokota, T., Ogawa, M., Expression of glycogen phosphorylase activity in minute gastric carcinoma. Am. J. Gastroenterol. 87 (1992), 1230–1231.
21. Shimada, S., Shiomori, K., Tashima, S., Tsuruta, J., Ogawa, M., Frequent p53 mutation in BGP foci in adjacent to human ‘de novo’ colorectal carcinoma. Br. J. Cancer 84 (2001), 1497–1504.
22. Shimada, S., Matsuzaki, H., Marutsuka, T., Shiomori, K., Ogawa, M., Gastric- and intestinal-phenotype of gastric carcinoma with reference to expression of brain (fetal)-type glycogen phosphorylase. J. Gastroenterol. 36 (2001), 457–464.
23. Shimada, S., Shiomori, K., Honmyo, U., Maeno, M., Yagi, Y., Ogawa, M., BGP expression in gastric may predict the development of new lesions after local treatment for early gastric cancer. Gastric Cancer 5 (2002), 130–136.